Aspen Pharmacare (APNJ.J) has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa, as it seeks to utilise its near-idle COVID-19 vaccine production lines in South Africa.
" not a great way to run a factory and to keep people employed with uncertainty," Saad said, referring to the lack of COVID-19 vaccine orders.
But he cautioned it would take at least 12 months for the production of new vaccines to begin. Until then Aspen still hoped to secure orders for Aspenovax. Aspen is also expecting to receive grants from the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations aimed at boosting affordable vaccine production.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Aspen seals deal with Serum Institute to make vaccines for AfricaAspen will be granted the rights to manufacture products from bulk a drug substance supplied by the world’s largest vaccine producer
Read more »
Africa: Across Africa, Many Young Mothers Face Education BarriersAnalysis - African Union Guidance, Policy Reforms Needed to Ensure Girls Continue Education
Read more »
Africa: How France Underdevelops AfricaAnalysis - Most sub-Saharan African French colonies got formal independence in the 1960s. But their economies have progressed little, leaving most people in poverty, and generally worse off than in other post-colonial African economies.
Read more »
Africa: Large-Scale Agricultural Projects Are Not Working for AfricaAnalysis - Big farming investments reduce local food security and erode trust. They need a fundamental rethink.
Read more »
'Bringing Tech Closer to Africa': Africa Tech Week kicks off in Cape TownThe Africa Tech Week brings experts together to assess the progress made in the sector as well as to map out objectives for Africa.
Read more »
MONEY LIVE | Aspen shares rocket 6% after results | Fin24MONEY LIVE | Aspen shares rocket 6% after results.
Read more »